Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1984 Nov;50(5):727–728. doi: 10.1038/bjc.1984.245

Are follicular large centrocytic and large centroblastic lymphomas one entity?

W M Molenaar, J Koudstaal, H Bartels
PMCID: PMC1976973  PMID: 6388615

Full text

PDF
727

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aine R., Alavaikko M., Kataja M. The Lukes and Collins classification of non-Hodgkin's lymphomas. 2. A survival study of 301 patients. Acta Pathol Microbiol Immunol Scand A. 1982 Jul;90(4):251–256. doi: 10.1111/j.1699-0463.1982.tb00089_90a.x. [DOI] [PubMed] [Google Scholar]
  2. Barcos M., Herrmann R., Pickren J. W., Naeher C., Han T., Stutzman L., Henderson E. S. The influence of histologic type on survival in non-Hodgkin's lymphoma. Cancer. 1981 Jun 15;47(12):2894–2900. doi: 10.1002/1097-0142(19810615)47:12<2894::aid-cncr2820471224>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  3. Cabanillas F., Smith T., Bodey G. P., Gutterman J. U., Freireich E. J. Nodular malignant lymphomas: factors affecting complete response rate and survival. Cancer. 1979 Dec;44(6):1983–1989. doi: 10.1002/1097-0142(197912)44:6<1983::aid-cncr2820440604>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  4. Herrmann R., Barcos M., Stutzman L., Walsh D., Freeman A., Sokal J., Henderson E. S. The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphoma. Cancer. 1982 Jan 15;49(2):314–322. doi: 10.1002/1097-0142(19820115)49:2<314::aid-cncr2820490218>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  5. Molenaar W. M., Bartels H., Koudstaal J. Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the "working formulation". Br J Cancer. 1984 Mar;49(3):263–268. doi: 10.1038/bjc.1984.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Molenaar W. M., van den Berg M., Halie M. R., Poppema S. The heterogeneity of follicular center cell lymphomas. I. Cytohistologic, immunologic, and enzymehistochemical aspects. Cancer. 1983 Dec 15;52(12):2269–2276. doi: 10.1002/1097-0142(19831215)52:12<2269::aid-cncr2820521219>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  7. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer. 1982 May 15;49(10):2112–2135. doi: 10.1002/1097-0142(19820515)49:10<2112::aid-cncr2820491024>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  8. Stein R. S., Cousar J., Flexner J. M., Graber S. E., McKee L. C., Krantz S., Collins R. C. Malignant lymphomas of follicular center cell origin in man. III. Prognostic features. Cancer. 1979 Dec;44(6):2236–2243. doi: 10.1002/1097-0142(197912)44:6<2236::aid-cncr2820440635>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  9. van den Berg H. M., Molenaar W. M., Poppema S., Halie M. R. The heterogeneity of follicular follicle center cell tumors. II. Clinical follow-up of 30 patients. Cancer. 1983 Dec 15;52(12):2264–2268. doi: 10.1002/1097-0142(19831215)52:12<2264::aid-cncr2820521218>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES